Terminated PHASE3 INTERVENTIONAL 2-arm NCT01506401

The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial (OSCILLATE)

The Oscillation for ARDS Treated Early (OSCILLATE) Trial

Sponsor: Canadian Critical Care Trials Group

Conditions Acute Respiratory Distress Syndrome (ARDS)

Interventions Lung Protective Ventilation SensorMedics 3100B High Frequency Oscillatory Ventilator

Updated 6 times since 2017 Last updated: Aug 5, 2015 Started: Jun 30, 2009 Primary completion: Sep 30, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Enrolment halted by Steering Committee on advice from Data Monitoring Committee.

Other terminated trials from Canadian Critical Care Trials Group

More terminations from Canadian Critical Care Trials Group

Other Acute Respiratory Distress Syndrome (ARDS) trials with similar outcome

Browse all Acute Respiratory Distress Syndrome (ARDS) trials

Listed as NCT01506401, this PHASE3 trial focuses on Acute Respiratory Distress Syndrome (ARDS) and remains terminated or withdrawn. Sponsored by Canadian Critical Care Trials Group, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Critical Care Trials Group
Canadian Institutes of Health Research (CIHR)
McMaster University
University of Toronto

Data source: Canadian Critical Care Trials Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Barrie, Canada , Calgary, Canada , Dallas, United States , Denver, United States , Edmonton, Canada , Greenville, United States , Hamilton, Canada , Houston, United States , Jeddah, Saudi Arabia and 15 more locations